|
|
Taiwan Academic Institutional Repository >
Browse by Title
|
Showing items 741541-741565 of 2351361 (94055 Page(s) Totally)
<< < 29657 29658 29659 29660 29661 29662 29663 29664 29665 29666 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2022-09-21T08:16:44Z |
Safeguarding medication use through interprofessional collaboration: Example of inpatient medication management and use
|
Yu H.-C.; Chen Y.-J.; Wu R.-S.; YUNN-FANG HO |
| 中國文化大學 |
2007 |
Safeguarding Taiwan's Globally Significant Biodviersty : Strengthening the Domestic Legal Framework and Participating in the Global biodiversity Governace System as an Ecological Entity
|
鄭欽哲 |
| 東海大學 |
2008 |
Safeguarding Taiwan’s national border: international pedophiles, mainland brides, and homosexual fraud husbands
|
Antonia Chao; 趙彥寧 |
| 東海大學 |
2008 |
Safeguarding Taiwan’s national border: international pedophiles, mainland brides, and homosexual fraud husbands.
|
Antonia Chao (趙彥寧) |
| 臺大學術典藏 |
2017 |
SaFePlay: A lightweight portable sensing system to estimate knee adduction moment
|
Wei, S.-Y. and Lo, Y.-P. and Lin, C.-Y. and Lin, T.-Y. and Chou, Y.-Y. and Huang, J.-T. and Yang, R.-S. and Hung, Y.-P.; RONG-SEN YANG |
| 臺大學術典藏 |
2021-05-31T02:56:55Z |
SaFePlay: A lightweight portable sensing system to estimate knee adduction moment
|
Wei S.-Y.;Lo Y.-P.;Lin C.-Y.;Lin T.-Y.;Chou Y.-Y.;Huang J.-T.;Rong-Sen Yang;Hung Y.-P.; Wei S.-Y.; Lo Y.-P.; Lin C.-Y.; Lin T.-Y.; Chou Y.-Y.; Huang J.-T.; RONG-SEN YANG; Hung Y.-P. |
| 臺大學術典藏 |
2021-03-19T01:31:35Z |
Safer way for vertebroplasty under fluid mechanics theory.
|
HSUAN-YU CHEN; Yen-Po Lin; Han Ying Wang; Feng Huei Lin; Po-Quang Chen; Ding-cheng Chan; Tze Hong Wong; Ming-Hsiao Hu |
| 國立成功大學 |
2023 |
Safest-path planning approach for indoor fire evacuation
|
Shih, G.-R.;Tsai, P.-H. |
| 嘉南藥理大學 |
2009 |
Safety & Security in Tourism
|
EBSCO-HTC |
| 國家衛生研究院 |
2016-06 |
Safety across subgroups in NAPOLI-1: A phase 3 study of nal-IRI (MM-398) +/- 5-fluorouracil and leucovorin (5-FU/LV) versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
|
Chen, LT;Siveke, J;Wang-Gillam, A;Hubner, R;Pant, S;Dragovich, T;Chung, V;Chang, D;Ross, P;Cooray, P;Tebbutt, N;Franke, F;Belanger, B;Dhindsa, N;de Jong, F;Mamlouk, K;Von Hoff, D |
| 國立臺灣大學 |
2012 |
Safety Analysis of FOLFOX4 Treatment in Colorectal Cancer Patients: A Comparison Between Two Asian Studies and Four Western Studies
|
Sugihara, Kenichi; Ohtsu, Atsushi; Shimada, Yasuhiro; Mizunuma, Nobuyuki; Lee, Po-Huang; de Gramont, Aimery; Goldberg, Richard M.; Rothenberg, Mace L.; Andre, Thierry; Brienza, Silvano; Gomi, Katsushige; 李伯皇 |
| 臺大學術典藏 |
2018-09-10T09:13:29Z |
Safety analysis of FOLFOX4 treatment in colorectal cancer patients: A comparison between two Asian studies and four western studies
|
Sugihara, K. and Ohtsu, A. and Shimada, Y. and Mizunuma, N. and Lee, P.-H. and De Gramont, A. and Goldberg, R.M. and Rothenberg, M.L. and André, T. and Brienza, S. and Gomi, K.; PO-HUANG LEE |
| 臺大學術典藏 |
2020-11-19T03:19:35Z |
Safety analysis of FOLFOX4 treatment in colorectal cancer patients: A comparison between two Asian studies and four western studies
|
Sugihara K.;Ohtsu A.;Shimada Y.;Mizunuma N.;Po-Huang Lee;De Gramont A.;Goldberg R.M.;Rothenberg M.L.;Andr? T.;Brienza S.;Gomi K.; Sugihara K.; Ohtsu A.; Shimada Y.; Mizunuma N.; PO-HUANG LEE; De Gramont A.; Goldberg R.M.; Rothenberg M.L.; Andr? T.; Brienza S.; Gomi K. |
| 淡江大學 |
2008-12 |
Safety Analysis of Level Crossing Surveillance Systems Using Fuzzy Petri Nets
|
Tao, Chi-chung; Lin,Tsung-chin |
| 臺大學術典藏 |
2022-09-06T08:33:56Z |
Safety and antibody response of recipients who unexpectedly received undiluted prime dose of BNT162b2 COVID-19 vaccine in Taiwan
|
Sheng, Wang-Huei; Wang, Chung-Cheng; Chu, Ching-Chi; Lin, Yueh-Juh; SUI-YUAN CHANG; Ieong, Si-Man; Chang, Shan-Chwen |
| 臺大學術典藏 |
2022-09-15T01:08:45Z |
Safety and Antitumor Activity of a-PD-L1 Antibody as Monotherapy or in Combination witha-TIM-3 Antibody in Patients with Microsatellite Instability-High/Mismatch Repair-Deficient Tumors
|
Hollebecque A.; Chung H.C.; Miguel M.J.D.; Italiano A.; MacHiels J.-P.; Chia-Chi Lin; Dhani N.C.; Peeters M.; Moreno V.; Su W.-C.; Chow K.H.; Galvao V.R.; Carlse M.; Yu D.; Szpurka A.M.; Zhao Y.; Schmidt S.L.; Gandhi L.; Xu X.; Bang Y.-J. |
| 國立成功大學 |
2021 |
Safety and Antitumor Activity of a-PD-L1 Antibody as Monotherapy or in Combination witha-TIM-3 Antibody in Patients with Microsatellite Instability-High/Mismatch Repair-Deficient Tumors
|
Hollebecque, A.;Chung, H.C.;Miguel, Miguel M.J.D.;Italiano, A.;MacHiels, J.-P.;Lin, C.-C.;Dhani, N.C.;Peeters, M.;Moreno, V.;Su, W.-C.;Chow, K.H.;Galvao, V.R.;Carlse, M.;Yu, D.;Szpurka, A.M.;Zhao, Y.;Schmidt, Schmidt S.L.;Gandhi, L.;Xu, Xu X.;Bang, Y.-J. |
| 臺大學術典藏 |
2022-08-19T00:20:40Z |
Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1-positive nasopharyngeal carcinoma: Results of the KEYnote-028 study
|
Hansen A.R.; Cheng J.D.; Thanigaimani P.; Saraf S.; CHIUN HSU; Lee S.-H.; Ejadi S.; Even C.; Cohen R.B.; Le Tourneau C.; Mehnert J.M.; Algazi A.; Van Brummelen E.M.J. |
| 臺大學術典藏 |
2020-04-10T12:51:01Z |
Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1-positive nasopharyngeal carcinoma: Results of the KEYNOTE-028 study
|
Chiun Hsu;Lee S.-H.;Ejadi S.;Even C.;Cohen R.B.;Le Tourneau C.;Mehnert J.M.;Algazi A.;Van Brummelen E.M.J.;Saraf S.;Thanigaimani P.;Cheng J.D.;Hansen A.R.; Chiun Hsu; Lee S.-H.; Ejadi S.; Even C.; Cohen R.B.; Le Tourneau C.; Mehnert J.M.; Algazi A.; Van Brummelen E.M.J.; Saraf S.; Thanigaimani P.; Cheng J.D.; Hansen A.R. |
| 臺大學術典藏 |
2020-05-25T07:35:07Z |
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer
|
Saraf S; Thanigaimani P; Cheng J.D; Keam B.; Mehnert J.M; Varga A; Brose M.S; Aggarwal R.R; Chia-Chi Lin; Prawira A; De Braud F; Tamura K; Doi T; Piha-Paul S.A; Gilbert J |
| 國立成功大學 |
2006-07 |
Safety and antiviral activity of pradefovir in patients with chronic hepatitis B virus infection: 48-week analysis of a phase 2 study
|
Lim, S. G.; Lee, K. S.; Chuang, W. L.; Hwang, S. G.; Cho, M.; Lai, M. Y.; Chao, Y. C.; Chang, Ting-Tsung; Han, K. H.; Lee, C. M.; Um, S. H.; Yeon, J. E.; Yang, S. S.; Teo, E. K.; Peng, C. Y.; Lin, H. H.; Yang, S. S.; Huo, T. I.; Nguyen, T.; Chen, T. Y.; Hu, K. Q.; Xu, Y.; Sullivan-Bolyai, J. Z. |
| 臺大學術典藏 |
2021-03-21T23:14:58Z |
Safety and clinical activity of a new anti-PD-L1 antibody as monotherapy or combined with targeted therapy in advanced solid tumors: The PACT phase Ia/Ib trial
|
Patnaik, Amita; Yap, Timothy A.; Chung, Hyun Cheol; de Miguel, Maria J.; Bang, Yung Jue; Chia-Chi Lin; Su, Wu Chou; Italiano, Antoine; Chow, Kay Hoong; Szpurka, Anna M.; Yu, Danni; Zhao, Yumin; Carlsen, Michelle; Schmidt, Shelly; Vangerow, Burkhard; Gandhi, Leena; Xu, Xiaojian; Bendell, Johanna |
| 臺大學術典藏 |
2022-09-15T01:08:50Z |
Safety and clinical activity of a new anti-PD-L1 antibody as monotherapy or combined with targeted therapy in advanced solid tumors: The PACT phase Ia/Ib trial
|
Patnaik A.; Yap T.A.; Chung H.C.; de Miguel M.J.; Bang Y.-J.; Chia-Chi Lin; Su W.-C.; Italiano A.; Chow K.H.; Szpurka A.M.; Yu D.; Zhao Y.; Carlsen M.; Schmidt S.; Vangerow B.; Gandhi L.; Xu X.; Bendell J. |
| 國立成功大學 |
2021 |
Safety and clinical activity of a new anti-PD-L1 antibody as monotherapy or combined with targeted therapy in advanced solid tumors: The PACT phase Ia/Ib trial
|
Patnaik, A.;Yap, T.A.;Chung, H.C.;de, Miguel M.J.;Bang, Y.-J.;Lin, C.-C.;Su, W.-C.;Italiano, A.;Chow, K.H.;Szpurka, A.M.;Yu, D.;Zhao, Y.;Carlsen, M.;Schmidt, Schmidt S.;Vangerow, B.;Gandhi, L.;Xu, Xu X.;Bendell, J. |
| 臺大學術典藏 |
2020-10-22T07:28:05Z |
Safety and effectiveness of adalimumab in patients with moderate-to-severe psoriasis who had inadequate therapeutic response to prior etanercept
|
Wang T.-S.;Tsen-Fang Tsai; Wang T.-S.; TSEN-FANG TSAI |
Showing items 741541-741565 of 2351361 (94055 Page(s) Totally)
<< < 29657 29658 29659 29660 29661 29662 29663 29664 29665 29666 > >>
View [10|25|50] records per page
|
